Inhibition of DNA cytosine methyltransferase by chemopreventive selenium compounds, determined by an improved assay for DNA cytosine methyltransferase and DNA cytosine methylation.

The organoselenium compounds benzyl selenocyanate (BSC) and 1,4-phenylenebis(methylene)selenocyanate (p-XSC), as well as sodium selenite, are effective chemopreventive agents for various chemically induced tumors in animal models at both the initiation and postinitiation stages. The mechanisms involved at the postinitiation stage are not clear. Because several lines of evidence indicate that inhibition of excess DNA (cytosine-5)-methyltransferase (Mtase) may be a sufficient factor for the suppression or reversion of carcinogenesis, we examined the effects of sodium selenite, BSC, p-XSC and benzyl thiocyanate (BTC), the sulfur analog of BSC, on Mtase activity in nuclear extracts of human colon carcinomas, and of p-XSC on the Mtase activity of HCT116 human colon carcinoma cells in culture. For this purpose, we developed an improved Mtase assay, in which the incorporation of the methyl-[3H] group from S-adenosyl[methyl-3H]methionine into deoxycytidine of poly(dI-dC)-poly(dI-dC), is specifically determined by HPLC with radioflow detection after enzymatic hydrolysis, enhancing specificity and reliability. In a variation, using SssI methyltransferase and labeled S-adenosylmethionine, the overall methylation status of DNA in various tissues can also be compared. Selenite, BSC and p-XSC inhibited Mtase extracted from a human colon carcinoma with IC50s of 3.8, 8.1 and 5.2 microM, respectively; BTC had no effect. p-XSC also inhibited the Mtase activity and growth of human colon carcinoma HCT116 cells, with an IC50 of approximately 20 microM. The improved Mtase assay should prove to be a reliable method for screening potential Mtase inhibitors, especially using cells in culture. We suggest that inhibition of Mtase may be a major mechanism of chemoprevention by selenium compounds at the postinitiation stage of carcinogenesis.

[1]  S. Baylin.  Tying It All Together: Epigenetics, Genetics, Cell Cycle, and Cancer , 1997, Science.

[2]  E. Fiala,et al.  Inhibition of 2-nitropropane-induced rat liver DNA and RNA damage by benzyl selenocyanate. , 1997, Carcinogenesis.

[3]  H. Makita,et al.  1,4-phenylenebis(methylene)selenocyanate exerts exceptional chemopreventive activity in rat tongue carcinogenesis. , 1997, Cancer research.

[4]  P. Jones,et al.  Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis. , 1997, Carcinogenesis.

[5]  A. Moser,et al.  Studies of neoplasia in the Min mouse. , 1997, Biochimica et biophysica acta.

[6]  M. Szyf,et al.  Inhibition of tumorigenesis by a cytosine-DNA, methyltransferase, antisense oligodeoxynucleotide. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[7]  S. Baylin,et al.  Increased cytosine DNA-methyltransferase activity is target-cell-specific and an early event in lung cancer. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. Herman,et al.  Expression of prokaryotic HhaI DNA methyltransferase is transforming and lethal to NIH 3T3 cells. , 1996, Cancer research.

[9]  A. Bird.  The relationship of DNA methylation to cancer. , 1996, Cancer surveys.

[10]  M. Szyf.  The DNA methylation machinery as a target for anticancer therapy. , 1996, Pharmacology & therapeutics.

[11]  S. Baylin,et al.  A microassay for measuring cytosine DNA methyltransferase activity during tumor progression. , 1995, Toxicology letters.

[12]  J. Herman,et al.  Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. , 1995, Cancer research.

[13]  G. Spyrou,et al.  AP‐1 DNA‐binding activity is inhibited by selenite and selenodiglutathione , 1995, FEBS letters.

[14]  A. deFazio,et al.  Inhibition of AP-1 binding and transcription by gold and selenium involving conserved cysteine residues in Jun and Fos. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[15]  R. Weinberg,et al.  Suppression of intestinal neoplasia by DNA hypomethylation , 1995, Cell.

[16]  M. Szyf,et al.  Expression of Antisense to DNA Methyltransferase mRNA Induces DNA Demethylation and Inhibits Tumorigenesis (*) , 1995, The Journal of Biological Chemistry.

[17]  Karam EI-Bayoumy.  Evaluation of chemopreventive agents against breast cancer and proposed strategies for future clinical intervention trials , 1994 .

[18]  J. Herman,et al.  Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[19]  K. El-Bayoumy.  Evaluation of chemopreventive agents against breast cancer and proposed strategies for future clinical intervention trials. , 1994, Carcinogenesis.

[20]  J. Herman,et al.  Expression of an exogenous eukaryotic DNA methyltransferase gene induces transformation of NIH 3T3 cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[21]  S. Baylin,et al.  Increased cytosine DNA-methyltransferase activity during colon cancer progression. , 1993, Journal of the National Cancer Institute.

[22]  C. Wagner,et al.  DNA methylation in folate deficiency: use of CpG methylase. , 1993, Biochemical and biophysical research communications.

[23]  H. Leonhardt,et al.  Structure, function and regulation of mammalian DNA methyltransferase. , 1993, EXS.

[24]  K. El-Bayoumy,et al.  Subchronic toxicity of benzyl selenocyanate and 1,4-phenylenebis(methylene)selenocyanate in F344 rats. , 1992, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[25]  K. El-Bayoumy,et al.  Chemoprevention of colon carcinogenesis by the synthetic organoselenium compound 1,4-phenylenebis(methylene)selenocyanate. , 1992, Cancer research.

[26]  B. Trask,et al.  Isolation and characterization of the cDNA encoding human DNA methyltransferase. , 1992, Nucleic acids research.

[27]  E. Fiala,et al.  Metabolism of [14C]benzyl selenocyanate in the F344 rat. , 1991, Chemical research in toxicology.

[28]  E. Fiala,et al.  Mechanism of benzylselenocyanate inhibition of azoxymethane-induced colon carcinogenesis in F344 rats. , 1991, Cancer research.

[29]  S. Baylin,et al.  High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R. Adams,et al.  Microassay for DNA methyltransferase. , 1991, Journal of biochemical and biophysical methods.

[31]  A. Feinberg,et al.  Reduced genomic 5-methylcytosine content in human colonic neoplasia. , 1988, Cancer research.

[32]  K. El-Bayoumy,et al.  Chemoprevention of colon carcinogenesis by dietary organoselenium, benzylselenocyanate, in F344 rats. , 1987, Cancer research.

[33]  S. Goorha,et al.  A study of the mechanism of selenite-induced hypomethylated DNA and differentiation of Friend erythroleukemic cells. , 1986, Carcinogenesis.

[34]  G. Pfeifer,et al.  Preferential binding of DNA methyltransferase and increased de novo methylation of deoxyinosine containing DNA , 1986, FEBS letters.

[35]  A. Weissbach,et al.  Mammalian DNA methyltransferases prefer poly(dI-dC) as substrate. , 1986, The Journal of biological chemistry.

[36]  H. Ganther.  Pathways of Selenium Metabolism Including Respiratory Excretory Products , 1986 .

[37]  C. Ip,et al.  The Chemopreventive Role of Selenium in Carcinogenesis , 1986, Advances in Experimental Medicine and Biology.

[38]  D. Medina,et al.  Mechanisms of Selenium Inhibition of Tumorigenesis , 1986, Advances in experimental medicine and biology.

[39]  A. Feinberg,et al.  Hypomethylation of DNA from benign and malignant human colon neoplasms. , 1985, Science.

[40]  R. Cox.  Selenite: a good inhibitor of rat-liver DNA methylase. , 1985, Biochemistry International.

[41]  D. Santi,et al.  Covalent bond formation between a DNA-cytosine methyltransferase and DNA containing 5-azacytosine. , 1984, Proceedings of the National Academy of Sciences of the United States of America.